StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Come for Covid, Stay for Cancer hard at work.

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Apr 05, 2021 1:17am

89 Views

Post# 32935965

RE:Come for Covid, Stay for Cancer hard at work.

Jonnyboy85 wrote: In the 3 months of Q4 2020 Cancer Testing totaled $384,334 which is more in one quarter than we made in the total 2 previous years.

2018 Total

$185,874

2019 Total

$138,704

End of Q1 2020

Cancer Testing $4,601

End of Q3 2020

Cancer Testing $88,729

2020 Total

$473,063